{"id":22966,"date":"2026-05-24T12:21:37","date_gmt":"2026-05-24T12:21:37","guid":{"rendered":"https:\/\/engineerbabu.com\/blog\/?p=22966"},"modified":"2026-05-24T16:30:22","modified_gmt":"2026-05-24T16:30:22","slug":"mental-health-app-development","status":"publish","type":"post","link":"https:\/\/engineerbabu.com\/blog\/mental-health-app-development\/","title":{"rendered":"Building a Mental Health Product for the US Market: 42 CFR Part 2, Crisis Flows, and the Therapist UX That Actually Works"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">In January 2023, a mental health founder in New York, Seed stage, $3.8M raised, building a platform connecting patients with licensed therapists for weekly video sessions, got a call from a therapist on her network. A patient had typed &#8220;I don&#8217;t want to be here anymore&#8221; into the in-platform chat during a session.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The therapist had seen it. The platform had not flagged it. There was no crisis protocol. There was no escalation workflow. There was no way for the therapist to alert a supervisor, document a safety assessment, or connect the patient to emergency services through the platform.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The therapist handled it correctly, she stayed on the call, did a suicide risk assessment verbally, and connected the patient to the 988 Suicide and Crisis Lifeline. The patient was safe.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The platform was not designed for that moment. The therapist&#8217;s training was. That gap, between what a skilled clinician knows to do and what the platform enables them to do, is a product failure. In mental health, it is also a patient safety failure.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A crisis flow is not a feature mental health products add in sprint 4. It is a feature mental health products build in sprint 1, before the first patient session goes live. Because the moment a patient types something that indicates they are in crisis, and they will, because your platform is where they come when they are struggling, your product must be ready.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">I have been on 2,000+ calls with US founders since 2014. Mental health founders consistently underestimate two things: how clinically complex their product actually is, and how much trust their patients are placing in them from the first session. Both of these truths live in the crisis flow.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22989\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh1_therapist_dashboard.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>Eight Things Mental Health Founders Get Wrong Before They Build<\/b><\/h2>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #1: &#8220;HIPAA covers everything we need for mental health.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.hhs.gov\/hipaa\/index.html\" target=\"_blank\" rel=\"noopener\">HIPAA<\/a> is the floor. 42 CFR Part 2 is an additional federal regulation that applies specifically to substance use disorder treatment records, with stricter confidentiality requirements than HIPAA. If your mental health platform serves patients with co-occurring substance use disorders (and most broad mental health platforms eventually do), Part 2 applies. Most agencies miss it entirely. The consent requirements for disclosure under Part 2 are more stringent than HIPAA, a general authorization does not suffice.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #2: &#8220;We&#8217;ll add the crisis flow later.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">No. The crisis flow goes in before the first patient session. Not sprint 3. Not after launch. Before the first real patient types their first real message. Mental health products are the only healthcare product category where the product itself may be the mechanism through which a patient communicates suicidal ideation or acute psychiatric crisis. Your platform must be designed for that moment from Day 1.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #3: &#8220;Our therapists know what to do, the product just needs to support the session.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Your therapists&#8217; clinical training is excellent. Your product must amplify that training, not create gaps in it. When a therapist on your platform identifies a patient in crisis, the product must enable them to: document the risk assessment, trigger a safety protocol, alert a supervisor, and, if necessary, connect the patient to emergency services. If the product does nothing, the therapist&#8217;s clinical skill alone is the only safeguard. That is not a product. That is a liability.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #4: &#8220;Mental health data is the same as other health data.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Mental health records are among the most sensitive data in healthcare. In most US states, mental health records carry additional legal protections beyond HIPAA, stricter access controls, more limited disclosure rights, and longer retention requirements. Psychotherapy notes (as defined by HIPAA at 45 CFR \u00a7164.501) have special protected status, they cannot be included in a general medical record disclosure and require a separate, specific authorization for release. Most engineers and agencies do not know this distinction.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #5: &#8220;We can use the same consent form as a general telehealth product.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Mental health-specific informed consent must address: the nature and limitations of telehealth-based mental health treatment, the risks of electronic communication in a mental health context, the platform&#8217;s crisis protocol, the limits of confidentiality (mandatory reporting obligations, child abuse, elder abuse, duty to warn), and, for products that use AI, the <a href=\"https:\/\/engineerbabu.com\/blog\/role-of-ai-in-modern-lab-diagnostics\/\">role of AI<\/a> in the therapeutic process. A general telehealth consent form does not cover these elements.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #6: &#8220;PSYPACT means our psychologists can practice in any state.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">PSYPACT allows licensed psychologists to practice across 42 member states under an Authority to Practice Interjurisdictional Telepsychology (APIT). It does not cover all psychologist license types, it does not cover licensed counselors or therapists (who have their own Counseling Compact), and it does not cover psychiatrists (who are physicians under the IMLC). Your platform&#8217;s licensure enforcement logic must handle multiple provider types, each with their own compact framework.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #7: &#8220;Engagement features that work in consumer apps work in mental health apps.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dark patterns, push notification urgency, streak mechanics, artificial scarcity, that drive engagement in consumer apps are clinically harmful in mental health products. A patient who feels anxious about breaking a therapy streak, or who is pushed to book a session by an aggressive notification campaign, is experiencing product-driven anxiety. Mental health product engagement must be designed by clinicians, not growth hackers.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Wrong #8: &#8220;AI therapy is the product.&#8221;<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">AI can augment mental health care. AI cannot replace a licensed therapist for the treatment of clinical mental health conditions. Products that position AI as the primary therapeutic intervention, without licensed clinician oversight, are operating outside the clinical and regulatory boundaries of mental health treatment. Build AI as a support layer: session preparation, between-session check-ins, mood tracking, psychoeducation. Not as the therapist.<\/span><\/p>\n<h2><b>What Makes Mental Health Products Different From Every Other Healthcare Build<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">I have shipped 140+ healthcare products since 2020. Mental health products are categorically different from every other healthcare vertical in ways that affect every layer of the build, data architecture, <a href=\"https:\/\/engineerbabu.com\/services\/ui-ux-design\">UX design<\/a>, clinical workflow, AI implementation, and regulatory compliance. Here is what actually makes them different.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>The data is uniquely sensitive:<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Mental health records contain information that patients share in a context of therapeutic trust, trauma histories, relationship disclosures, suicidal ideation, substance use, sexual behavior, legal history. This information, if disclosed improperly, can affect employment, insurance coverage, custody determinations, immigration status, and personal relationships in ways that most health data cannot. The engineering team building a mental health product must understand this sensitivity, not just as a compliance requirement, but as a design constraint that affects every access control decision, every analytics implementation, and every AI feature.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Psychotherapy notes have special legal status:<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Under HIPAA (45 CFR \u00a7164.501), psychotherapy notes are defined specifically as notes recorded by a mental health professional in the process of counseling, that are separated from the rest of the medical record. These notes have heightened protection, they cannot be included in a general medical record disclosure, they require a separate specific authorization for release (beyond a general HIPAA authorization), and they are exempt from the patient&#8217;s right of access under certain conditions. Most EHRs and most healthcare products do not distinguish psychotherapy notes from general clinical notes. Your mental health product must.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>The platform is present at moments of acute crisis:<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">No other healthcare product category is routinely present at moments of suicidal ideation, acute psychiatric crisis, or medical emergency triggered by mental health symptoms. A blood pressure monitoring app is not present when a patient is in crisis. A diabetes management app is not the medium through which a patient communicates that they want to end their life. A mental health platform is. The product must be designed for these moments, not as edge cases, but as expected events in the clinical experience of your user population.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Mandatory reporting creates a confidentiality exception your product must handle:<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Mental health professionals have mandatory reporting obligations in every US state, duty to warn (Tarasoff obligations), duty to report child abuse, duty to report elder abuse, and in some states duty to report certain infectious diseases. These mandatory reporting obligations create a confidentiality exception that your product must support operationally: the therapist needs to be able to document a mandatory report within the platform, flag the clinical record, and in some cases notify the appropriate authority through a documented workflow. The product cannot be designed as if all mental health disclosures are confidential, some are not, by law.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Provider burnout is a product design problem:<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The mental health provider workforce is in a documented burnout crisis. Therapists who burn out leave platforms. Therapist turnover is the single largest predictor of patient churn on mental health platforms. The product design decisions that contribute to or mitigate provider burnout, documentation burden, scheduling friction, between-session message volume, administrative load, are retention metrics, not just UX preferences. Build for therapist sustainability, not just patient engagement.<\/span><\/p>\n<p><b>From a US founder call:<\/b><span style=\"font-weight: 400;\"> &#8220;I hired a UX agency to design my mental health platform. They designed for patient engagement, gamification, streaks, push notifications. My clinical advisors reviewed the designs in week four and flagged that three of the engagement features were clinically contraindicated for patients with anxiety disorders. We rebuilt the patient experience from scratch. The UX agency had never worked on a mental health product before. That cost me twelve weeks and $85,000. Mental health UX requires clinical oversight, not just user research.&#8221;, Series A mental health founder, NYC.<\/span><\/p>\n<h2><b>The Regulatory Stack: HIPAA + 42 CFR Part 2 + State Mental Health Laws<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Mental health products operate under a layered regulatory framework. HIPAA is the baseline. 42 CFR Part 2 adds a layer for SUD records. State mental health laws add a third layer that varies dramatically by state. Here is the full picture.<\/span><\/p>\n<h3><b>1. HIPAA, The Baseline<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">All mental health records that are electronically stored or transmitted by a HIPAA Covered Entity or Business Associate are ePHI under HIPAA. The Privacy Rule, Security Rule, and Breach Notification Rule all apply. Psychotherapy notes carry additional protection under 45 CFR \u00a7164.501 and \u00a7164.508(a)(2), they require a separate specific authorization for most disclosures, separate from the general authorization for other PHI.<\/span><\/p>\n<p><b>The psychotherapy notes distinction in practice:<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Your data model must separate psychotherapy notes from the general clinical record. A psychotherapy note is the therapist&#8217;s process notes, their observations, hypotheses, and reflections from the session. It is not the clinical summary, the diagnosis, the treatment plan, or the medication record, those are part of the general medical record and subject to standard HIPAA access rules. Keeping these separate in the data model is not an optional best practice. It is a HIPAA requirement under \u00a7164.501.<\/span><\/p>\n<h3><b>2. 42 CFR Part 2, Substance Use Disorder Records<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">42 CFR Part 2 applies to any program that holds itself out as providing substance use disorder diagnosis, treatment, or referral for treatment, or any record that identifies a patient as having received SUD treatment from such a program. It imposes stricter confidentiality requirements than HIPAA:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Disclosure requires patient consent that specifically names each entity to whom disclosure is made, the purpose of the disclosure, and how much information can be disclosed. A general HIPAA authorization does not satisfy Part 2.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Redisclosure is prohibited, a recipient of Part 2-protected information cannot re-disclose it without a new patient authorization, except in specific circumstances.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Court orders require a special two-step process, a subpoena alone is not sufficient to compel disclosure.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Breach notification under Part 2 follows the HIPAA framework but with stricter access controls on the underlying records.<\/span><\/li>\n<\/ul>\n<p><b>When does Part 2 apply to your mental health platform?<\/b><\/p>\n<p><span style=\"font-weight: 400;\">If your platform serves patients with co-occurring substance use disorders (which most broad mental health platforms do), if you explicitly treat or refer for SUD, or if your platform stores records that could identify a patient as having received SUD treatment, Part 2 likely applies. The applicability question is not always clear-cut. Get a healthcare attorney&#8217;s opinion on Part 2 applicability before you design your data model. Retrofitting Part 2 compliance into a data model that was not designed for it is expensive.<\/span><\/p>\n<p><b>The 2020 Part 2 Final Rule update:<\/b><span style=\"font-weight: 400;\"> The 2020 HHS final rule aligned Part 2 somewhat more closely with HIPAA, allowing a single consent to be used for treatment, payment, and operations purposes, and permitting disclosure to other treating providers without separate consent for treatment purposes. These changes made Part 2 somewhat less operationally burdensome than the pre-2020 framework. The alignment is partial, Part 2 is still materially stricter than HIPAA in most contexts. Confirm current Part 2 requirements with your healthcare attorney.<\/span><\/p>\n<h3><b>3. State mental health laws<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Every US state has state-specific mental health privacy laws that may impose requirements beyond HIPAA and Part 2. Key examples:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>California: <\/b><span style=\"font-weight: 400;\">The Lanterman-Petris-Short Act governs involuntary psychiatric holds (5150 holds). The Confidentiality of Medical Information Act (CMIA) imposes requirements on mental health information that go beyond HIPAA. Psychotherapy notes have particularly strong protection under California law.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>New York:<\/b><span style=\"font-weight: 400;\"> New York Mental Hygiene Law imposes specific confidentiality requirements for mental health records. The New York SHIELD Act adds data security requirements.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Texas:<\/b><span style=\"font-weight: 400;\"> Texas Health and Safety Code Chapter 611 governs mental health records with requirements that differ from HIPAA in specific ways.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Illinois:<\/b><span style=\"font-weight: 400;\"> Illinois Mental Health and Developmental Disabilities Confidentiality Act imposes requirements stricter than HIPAA for mental health records.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If your platform operates across multiple states, and most mental health platforms do, a state-by-state mental health privacy law review is a required pre-build investment. Budget $8K\u2013$20K for a comprehensive multi-state review.<\/span><\/p>\n<p><b>Compliance trap:<\/b><span style=\"font-weight: 400;\"> A mental health platform that does not separate psychotherapy notes from the general clinical record in its data model is making every psychotherapy note subject to the same access and disclosure rules as a general medical record. This is a HIPAA violation under \u00a7164.501.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The separation is not a UI feature, it is a data model decision that must be made in Week 1 of discovery. Every feature that touches clinical notes must know whether it is reading a psychotherapy note or a general clinical record and apply the appropriate access controls to each.<\/span><\/p>\n<p><b>Red flag:<\/b><span style=\"font-weight: 400;\"> Any development agency working on a mental health product that does not ask about 42 CFR Part 2 applicability in the first week of discovery has not worked on a serious mental health product before. Part 2 is not an edge case for mental health products serving broad patient populations, it is a baseline regulatory question that must be addressed before the data model is designed.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22993\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh3_patient_app.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>The 15-Question Mental Health Product Readiness Audit<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Before your engineering team writes a line of code, work through these fifteen questions. Each one is an architecture, clinical, or compliance decision that is cheaper to make explicitly in discovery than to discover implicitly post-launch.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is the clinical scope of your platform?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Therapy only (licensed therapists, weekly sessions)? Psychiatry (medication management + therapy)? Coaching (non-licensed, not clinical treatment)? Peer support (lived experience, not licensed)? The clinical scope determines your regulatory requirements. Coaching is not mental health treatment and is not subject to HIPAA if no PHI is collected from a Covered Entity. Licensed therapy is clinical treatment and is subject to HIPAA, state mental health laws, and potentially Part 2. Know your scope before you design anything.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Will your platform serve patients with substance use disorders?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If yes, or if it is likely, 42 CFR Part 2 applies. Get a healthcare attorney&#8217;s Part 2 applicability opinion before designing your data model.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Which provider types will practice on your platform?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Licensed Professional Counselors (LPCs), Licensed Clinical Social Workers (LCSWs), Marriage and Family Therapists (MFTs), Psychologists (PhD\/PsyD), Psychiatrists (MD\/DO), Certified Peer Support Specialists, Coaches. Each has a different licensing framework, different prescribing authority (psychiatrists can prescribe; most others cannot), and different compact coverage.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Which states will you launch in, and do your providers hold active licenses in those states?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The same licensure enforcement requirement as general telehealth, the patient&#8217;s physical location at the time of the encounter determines which state&#8217;s mental health practice laws apply.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Will your platform facilitate psychiatric medication management?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If yes, you need psychiatrists or psychiatric nurse practitioners on the platform with prescribing authority. The ePrescribe integration is required, including EPCS for controlled substances (benzodiazepines, stimulants for ADHD, and certain other psychiatric medications are Schedule IV or Schedule II). The prescribing regulatory framework for psychiatric medications via telehealth follows the same post-PHE DEA rules as general telehealth prescribing.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Have you designed your crisis protocol?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Who is the responsible party when a patient indicates suicidal ideation or acute psychiatric crisis in a session or in the platform chat? What does the platform enable the therapist to do? What is the escalation path if the therapist cannot reach the patient? What is the documentation workflow for a safety assessment? What is the platform&#8217;s role in connecting the patient to emergency services?<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>How will your platform handle mandatory reporting obligations?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Duty to warn, duty to report child abuse, duty to report elder abuse, these are mandatory reporting obligations that mental health providers have in every US state. The requirements vary by state (who is a mandated reporter, what triggers the reporting obligation, who is the report made to, and the timeline). Your platform must support the documentation and reporting workflow for mandatory reports.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Have you designed your psychotherapy notes data model?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Psychotherapy notes must be stored separately from the general clinical record in your data model. The access controls on psychotherapy notes are more restrictive than general clinical notes. The disclosure rules are different. This is a data model decision, not a UI decision, and it must be made in Week 1 of discovery.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is your approach to between-session communication?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Secure messaging between patients and therapists between sessions is a high-value feature for patient engagement and clinical outcomes. It is also a significant clinical and operational risk if not designed carefully. Unlimited, unstructured between-session messaging creates provider burnout. No between-session communication creates patient disengagement between sessions. Design the between-session communication model with clinical input before you build it.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>How will you handle patient-generated content that indicates risk?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">In-app mood tracking, journaling, and symptom check-ins generate patient-reported data that may indicate clinical deterioration or acute risk. Will your platform algorithmically flag entries that indicate risk? If yes, who receives the flag, what is the clinical response protocol, and how is the flag documented? If your platform surfaces a risk flag to a therapist, does that create a legal duty of care that the platform must then support?<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is your approach to engagement design?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Who has clinical oversight of your engagement design decisions, push notification cadence, reminder messaging, streak mechanics, urgency language? Engagement features that are clinically inappropriate for populations with anxiety, depression, or trauma histories must be identified and removed before launch. This requires clinical review of every engagement feature.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Will you use AI in the clinical workflow?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Session summaries, progress note generation, between-session check-in analysis, risk flag detection, each AI use case in a mental health product carries a clinical risk profile that must be evaluated before implementation. Get clinical oversight of every AI feature in your mental health product.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is your informed consent framework?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Who drafts the mental health-specific informed consent? Does it address: telehealth-based treatment limitations, crisis protocol, mandatory reporting limits of confidentiality, between-session communication expectations, <a href=\"https:\/\/engineerbabu.com\/blog\/8-benefits-of-using-ai-for-clinical-diagnosis\/\">AI use in the clinical process<\/a>, and data practices? A healthcare attorney with mental health specialty experience should draft this, not your general counsel and not your engineering team.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is your clinical quality assurance process?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">How do you ensure clinical quality on your platform? Who reviews therapist performance? What happens when a patient complaint has clinical dimensions? Who is the medical director or clinical director responsible for clinical oversight of the platform? These are regulatory and liability questions in addition to operational ones, most state mental health licensing boards expect platforms operating in their state to have documented quality assurance processes.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is your data retention and deletion policy for mental health records?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">HIPAA minimum: 6 years. California mental health records: 10 years from the date of service for adult patients (7 years from the last date of service for minors, or until the minor turns 19, whichever is longer). Some states require longer retention for mental health records specifically. Build your retention policy around the most restrictive requirement that applies to your patient population, and build the deletion workflow before you have records that need to be deleted.<\/span><\/p>\n<h2><b>The Data Architecture for Mental Health Products, What You Store, What You Don&#8217;t<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Mental health products have a more complex data model than most healthcare products because of the multiple legal categories of clinical information that must be stored separately and governed by different access rules.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Patient profile data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Name, date of birth, address, phone, email, insurance ID, emergency contact, preferred pharmacy (if psychiatric medication management is in scope). Standard PHI under the 18 HIPAA identifiers. Encrypted at rest. Access: patient (self), care coordinator, billing (insurance fields only), treating provider.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Clinical assessment data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Intake questionnaire responses, PHQ-9 (depression screening), GAD-7 (anxiety screening), PCL-5 (PTSD screening), AUDIT (alcohol use screening), DAST (drug use screening), Columbia Suicide Severity Rating Scale (C-SSRS) results. These are ePHI. They are also clinically sensitive in a way that requires care about who can access them and under what circumstances. For platforms with Part 2 applicability: any screening result that identifies a patient as having a substance use disorder is subject to Part 2 protections.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Diagnosis data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">ICD-10 diagnosis codes assigned by the treating provider. Part of the general clinical record. Access: treating provider (read\/write), supervising provider, billing (for claims), patient (right of access under HIPAA). Not included in general administrative disclosures without authorization.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Treatment plan data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The documented treatment plan, therapeutic goals, modality, frequency, expected duration. Part of the general clinical record. Access: treating provider, supervising provider, patient. For Part 2-applicable platforms: if the treatment plan addresses SUD treatment, it is subject to Part 2 protections.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>General progress notes<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Session-level clinical documentation that is part of the medical record, date of service, session type, clinical themes addressed, patient response, plan for next session. These are standard clinical records subject to standard HIPAA access and disclosure rules. They are not psychotherapy notes as defined by HIPAA.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Psychotherapy notes (the special category)<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The therapist&#8217;s private process notes, their reflections, hypotheses, countertransference observations, and interpretations that they record for their own clinical use. These must be stored in a separate data store from the general clinical record, with more restrictive access controls. Access: treating therapist only (by default). A separate, specific patient authorization is required for any disclosure beyond the treating therapist. The patient&#8217;s right of access does not automatically extend to psychotherapy notes, the covered entity can deny access to psychotherapy notes under \u00a7164.524(a)(1)(i).<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Safety assessment data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">C-SSRS results, safety planning documentation, crisis episode records, mandatory reporting documentation. These are among the most sensitive records in the system. Access: treating provider, supervising provider, clinical director. They must be retained with particular care, they are often requested in legal proceedings and licensing board inquiries.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Between-session communication<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Secure messages between patients and therapists between sessions. If the messages contain mental health information, they are ePHI. They must be stored with encryption at rest, audit logged, and subject to the same access controls as other clinical records. For Part 2-applicable platforms: messages that contain SUD-related disclosures are subject to Part 2 protections.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Mood tracking and patient-generated data<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Patient-reported mood scores, journal entries, symptom check-ins, sleep and activity data (if integrated with wearables). These are ePHI if they are linked to an individually identified patient in a healthcare context. They require encrypted storage, access controls, and audit logging.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>AI-generated clinical content<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Session summaries, progress note drafts, risk flag outputs, any content generated by AI based on clinical session data or patient-generated data. These are ePHI if they contain individually identifiable health information. They must be stored with the same protections as the source clinical data.<\/span><\/p>\n<p><b>What we&#8217;d cut:<\/b><span style=\"font-weight: 400;\"> For a mental health MVP focused on therapy (not psychiatry), a Lean data model covers: patient profile, intake assessment (PHQ-9, GAD-7, C-SSRS), diagnosis (ICD-10), treatment plan, session notes (general progress notes only, psychotherapy notes are a separate data store from Day 1), safety assessment, and between-session secure messaging. Add mood tracking and AI-generated content in sprint 2. Add Part 2 SUD-specific data governance in sprint 3 as the patient population expands. Design the psychotherapy notes separation from Day 1, it cannot be retrofitted.<\/span><\/p>\n<h2><b>Crisis Flow Design, The Feature That Cannot Fail<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The crisis flow is the most important feature in a mental health product. It must work correctly the first time a patient needs it, in every scenario, on every device, in every state. Here is how we design and build it.<\/span><\/p>\n<h3><b>The clinical scenarios the crisis flow must handle:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Scenario 1: Patient discloses suicidal ideation during a live session.<\/b><span style=\"font-weight: 400;\"> The therapist identifies the disclosure. The therapist must be able to: (a) conduct and document a structured suicide risk assessment (C-SSRS) within the platform, (b) create a safety plan collaboratively with the patient and store it in the record, (c) alert a supervisor or clinical director if the risk level warrants escalation, (d) access the patient&#8217;s emergency contact information and document contact attempts, (e) access the 988 Suicide and Crisis Lifeline and local emergency services information within the platform, and (f) document the full crisis encounter in the clinical record with timestamp accuracy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Scenario 2: Patient sends a message indicating crisis outside of a session.<\/b><span style=\"font-weight: 400;\"> A patient sends a chat message, &#8220;I&#8217;ve been thinking about hurting myself&#8221;, at 11 PM between sessions. The platform must: (a) detect potential crisis language (through keyword matching, AI risk scoring, or both), (b) immediately surface a crisis response to the patient within the platform (988 information, Crisis Text Line, local emergency services), (c) alert the treating therapist and a clinical on-call supervisor, (d) create a crisis record documenting the message, the timestamp, the automated response provided, and the therapist notification, and (e) log the event for clinical quality review.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Scenario 3: Patient does not show for a session and cannot be reached.<\/b><span style=\"font-weight: 400;\"> The therapist attempts to join the session. The patient does not appear. The therapist has reason to believe the patient may be at elevated risk (prior suicidal ideation, recent crisis episode, known high-risk period). The platform must: (a) enable the therapist to initiate a welfare check workflow within the platform, (b) provide the patient&#8217;s emergency contact information and document contact attempts, (c) provide local emergency services information for the patient&#8217;s location, and (d) document the welfare check attempt and outcome in the clinical record.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Scenario 4: Patient discloses imminent danger to another person (duty to warn).<\/b><span style=\"font-weight: 400;\"> In states with Tarasoff-type duty to warn statutes, a therapist who becomes aware of a patient&#8217;s serious, imminent threat to an identifiable third party has a legal duty to take steps to protect that person, which may include warning the intended victim, notifying law enforcement, or both, depending on state law. The platform must enable the therapist to document the threat disclosure, document the clinical assessment, document the actions taken (who was warned, when, how), and store this documentation with heightened security given its legal sensitivity.<\/span><\/li>\n<\/ul>\n<h3><b>The crisis flow architecture:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Risk language detection:<\/b><span style=\"font-weight: 400;\"> Keyword and phrase matching for explicit crisis language in patient-generated text (chat messages, journal entries, mood tracking free text). Categories: suicidal ideation (explicit statements, implied statements), self-harm, harm to others, acute psychiatric symptoms. This is not sufficient alone, it must be paired with clinical escalation, not just automated messaging. <\/span>Honest note on AI risk detection: AI-based NLP models for suicide risk detection have documented false positive and false negative rates. They are useful as a first-line signal, not as a clinical assessment. Every risk flag generated by AI must be reviewed by a clinician, the AI flags, the clinician assesses. Do not build an AI system that autonomously determines a patient is not in crisis.<\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Automated in-product crisis resources:<\/b><span style=\"font-weight: 400;\"> When a risk signal is detected, by keyword match, by AI flag, or by therapist action, the platform immediately surfaces crisis resources to the patient: 988 Suicide and Crisis Lifeline (call or text), Crisis Text Line (text HOME to 741741), local emergency services (911), and the patient&#8217;s designated emergency contact. These resources must be surfaced within the product, not as an external link the patient may not follow. They must be accessible in under two taps from anywhere in the application.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Therapist crisis tools:<\/b><span style=\"font-weight: 400;\"> Embedded C-SSRS: a structured, validated suicide risk assessment tool available within the session interface. The therapist can complete the C-SSRS with the patient during the session and the completed assessment is automatically saved to the patient&#8217;s clinical record with timestamp. Safety planning tool: a collaborative safety planning interface that generates a structured safety plan (Stanley-Brown Safety Planning Intervention format) that is stored in the patient&#8217;s record and can be sent to the patient as a reference document.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Clinical escalation workflow:<\/b><span style=\"font-weight: 400;\"> When a therapist determines that a patient&#8217;s risk level requires escalation, beyond what they can manage individually, the platform provides a one-click escalation to the clinical on-call supervisor. The escalation creates a record: who escalated, when, what the clinical concern was, who the on-call supervisor is, and when they responded. For platforms with an after-hours on-call model, the escalation must work at 11 PM on a Saturday as reliably as it works at 2 PM on a Tuesday.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Crisis documentation:<\/b><span style=\"font-weight: 400;\"> Every crisis-related event generates a structured clinical record: the trigger (patient statement, therapist observation, AI flag), the clinical assessment conducted (C-SSRS score, clinical judgment), the actions taken (safety planning, emergency services contacted, supervisor escalated), the outcome (patient contracted for safety, 911 called, voluntary hospitalization arranged), and the follow-up plan. This record is retained with heightened security and is subject to the same 6+ year retention requirement as all ePHI.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Post-crisis follow-up workflow:<\/b><span style=\"font-weight: 400;\"> After a crisis episode, the platform must support the follow-up clinical protocol: scheduled follow-up contact within 24\u201348 hours, documentation of the follow-up contact, updated safety plan, and flagging of the patient&#8217;s record for enhanced clinical monitoring. A crisis is not a closed event when the session ends. The platform must support the ongoing clinical response.<\/span><\/li>\n<\/ul>\n<p><b>Red flag:<\/b><span style=\"font-weight: 400;\"> Any mental health product that does not have a crisis flow designed, built, and tested before the first patient session goes live is not ready for clinical deployment. There is no &#8220;soft launch&#8221; for crisis. The first patient who needs the crisis flow will not wait for sprint 4.<\/span><\/p>\n<p><b>From a US founder call:<\/b><span style=\"font-weight: 400;\"> &#8220;We built the crisis flow before we built anything else. Not because we were being cautious, because our clinical advisory board told us it was non-negotiable. Our first patient session went live in week 14 of the build. In week 16, a patient disclosed suicidal ideation in a session.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The crisis flow worked. The therapist completed the C-SSRS within the platform, created a safety plan, escalated to the on-call supervisor, and documented the full encounter. The patient was safe. The documentation was complete. That moment is why you build the crisis flow first.&#8221;, Seed-stage mental health founder, Seattle.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22999\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh2_crisis_flow-1.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>The Therapist UX Playbook, What Clinicians Actually Need<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Therapist retention is the most important operational metric on a mental health platform. Therapists who are frustrated by the product leave. Patients follow their therapist, not the platform. Every therapist who leaves takes their caseload with them.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The therapist UX decisions that drive retention:<\/span><\/p>\n<h3><b>1. Documentation time is the enemy:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The single most cited frustration among therapists on digital mental health platforms is documentation time. A 50-minute therapy session should not require 30 minutes of post-session documentation. The therapist UX must minimize documentation burden through: structured note templates that pre-populate from session data, AI-assisted SOAP note generation from session transcription (with therapist review and edit), auto-populated diagnosis codes from the treatment plan, and one-click carry-forward of stable information from previous sessions.<\/span><\/p>\n<p><b>EB Index 2026:<\/b><span style=\"font-weight: 400;\"> Across 18 mental health products we have shipped, platforms that implemented AI-assisted progress note generation saw therapist documentation time decrease by an average of 14 minutes per session. At a caseload of 25 patients per week, that is 350 minutes, nearly 6 hours, of therapist time recovered weekly. Provider NPS on platforms with AI-assisted documentation averaged 58 versus 31 on platforms without it.<\/span><\/p>\n<h3><b>2. Between-session message management:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Unlimited, unstructured between-session messaging is a therapist burnout driver. Therapists who feel obligated to respond to patient messages at all hours experience boundary erosion that accelerates burnout. The between-session messaging model must be designed with clinical input:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Define response time expectations (24-hour response during business days, crisis resources for after-hours urgent concerns)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Batch message delivery to the therapist (rather than real-time push for every patient message) with a daily digest model<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Flag messages that contain risk language for priority review, separate from routine messages<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Give therapists tools to set availability windows and automated responses for off-hours messages<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Make it easy for therapists to document that a between-session message was clinically relevant and constitutes a billable service (many state Medicaid programs and some commercial payers reimburse asynchronous communication)<\/span><\/li>\n<\/ul>\n<h3><b>3. Scheduling that respects clinical boundaries:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Therapists who cannot control their schedules, who are auto-booked to capacity by the platform&#8217;s matching algorithm, burn out faster than therapists who have meaningful schedule control. The scheduling UX must give therapists: the ability to set their own availability windows including buffer time between sessions, the ability to block time for documentation and administrative tasks, the ability to limit their caseload size at any given time, and the ability to decline a patient match for any reason.<\/span><\/p>\n<h3><b>4. Caseload visibility:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Therapists need to see their full caseload in one view, every active patient, their last session date, their next scheduled session, their risk level, and any outstanding documentation. This is not a nice-to-have dashboard feature, it is the clinical tool that allows a therapist to manage their caseload proactively rather than reactively. A therapist who cannot see at a glance which patients have not been seen in three weeks, or which patients have elevated PHQ-9 scores from last week&#8217;s check-in, is managing their caseload blindly.<\/span><\/p>\n<h3><b>5. Supervision and consultation tools:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Many therapists, particularly early-career LPCs, LCSWs, and MFTs, are required by their license to receive clinical supervision. Your platform must support the supervision relationship: the ability for a supervising clinician to review session notes, provide documented feedback, co-sign notes where required by state law, and conduct supervision sessions within the platform. Platforms that support supervision as a first-class feature attract early-career therapists who are building their caseload, a high-growth segment of the mental health workforce.<\/span><\/p>\n<h3><b>6. Payment transparency and reliability:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Therapists who are not paid correctly and on time leave quickly. The payment model, per-session fee, hourly rate, revenue share, must be transparent, calculable in advance, and paid reliably. A therapist dashboard that shows expected earnings for the next pay period, payment history, and session-by-session earnings detail is not a luxury feature. It is a retention feature.<\/span><\/p>\n<p><b>What we&#8217;d cut:<\/b><span style=\"font-weight: 400;\"> For a mental health <a href=\"https:\/\/engineerbabu.com\/services\/mvp-development\">MVP development<\/a>, the minimum viable therapist UX is: caseload dashboard, session scheduling with therapist-controlled availability, HIPAA-compliant video session with the crisis flow embedded, post-session progress note template, and earnings visibility.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">AI-assisted note generation and between-session message management are sprint 2. Supervision tools and advanced caseload analytics are sprint 3. Build what therapists need to do the clinical work first. Build what makes the platform easier to run second.<\/span><\/p>\n<h2><b>The Patient UX Playbook, Engagement Without Dark Patterns<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Mental health product engagement must be designed around clinical outcomes, not retention metrics. These are related, a patient who engages consistently with their therapy sessions has better outcomes, and better outcomes drive retention. But the path to engagement in a mental health product is clinical integrity, not growth hacking.<\/span><\/p>\n<h3><b>1. Onboarding:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The mental health onboarding experience is the moment of highest vulnerability for a patient seeking care. They are disclosing that they need help, that takes courage, and it takes trust. The onboarding flow must honor that moment:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Short, clinically validated intake (PHQ-9, GAD-7, C-SSRS for safety screening) that communicates clinical purpose, not a generic &#8220;tell us about yourself&#8221; consumer form<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Immediate value in the provider match, show the patient why their matched therapist is right for them (specialty, approach, demographic concordance if requested)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Informed consent that is plain-language and honest, not buried in legal text<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A first session scheduled within 48\u201372 hours of matching, the research on mental health care engagement consistently shows that longer wait times between matching and first session dramatically reduce first-session show rates<\/span><\/li>\n<\/ul>\n<h3><b>2. Between-session engagement:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">The clinical touchpoints between sessions drive outcomes and retention:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mood check-ins (1\u20132 minutes, validated instruments like the PHQ-2 or GAD-2 for brief between-session screening) surfaced 2\u20133 times per week, not daily, not multiple times per day<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pre-session preparation prompts (24 hours before the session: &#8220;What would you like to focus on in tomorrow&#8217;s session?&#8221;)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Post-session reflection prompts (24 hours after the session: &#8220;What is one thing from today&#8217;s session that you want to keep thinking about?&#8221;)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Psychoeducation content, short, evidence-based articles or exercises relevant to the patient&#8217;s treatment focus, delivered asynchronously between sessions<\/span><\/li>\n<\/ul>\n<h3><b>3. Notification design:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reminders for scheduled sessions: yes, SMS and in-app, 24 hours before and 1 hour before<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Crisis resource reminder: a persistent, low-prominence crisis resource link accessible from any screen in the app<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Between-session check-in reminders: once per scheduled check-in, not repeated until the patient completes or dismisses<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Everything else: off by default, patient-controlled<\/span><\/li>\n<\/ul>\n<h3><b>4. What we do not build in mental health engagement:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Streak mechanics (breaking a therapy streak should not cause anxiety in a patient seeking anxiety treatment)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Urgency language in notifications (&#8220;Your mental health needs you!&#8221; is clinically inappropriate)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Comparison features (&#8220;Patients like you who do 3 sessions per week see 40% better outcomes&#8221;, this is not how evidence-based care works and it is not appropriate for a clinical product)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gamification of clinical assessments (a PHQ-9 score is not a game score)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Auto-renewal of therapy subscriptions without explicit patient confirmation (predatory in any context; particularly harmful in a mental health context where a patient may be in a vulnerable state)<\/span><\/li>\n<\/ul>\n<h3><b>5. Access to records:<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Under HIPAA&#8217;s right of access (\u00a7164.524), patients have the right to access their own health information. Your mental health product must support this, a patient-facing view of their clinical records including intake assessments, diagnosis, treatment plan, and progress notes. The exception is psychotherapy notes (\u00a7164.524(a)(1)(i)), the covered entity may deny patient access to psychotherapy notes. Make this distinction clear in the patient experience and in your informed consent documentation.<\/span><\/p>\n<p><b>From a US founder call:<\/b><span style=\"font-weight: 400;\"> &#8220;We had a growth advisor tell us to add streak mechanics to drive daily app opens. Our clinical director said no in the first review, she had worked with anxiety patients for fifteen years and knew that a broken streak would cause more anxiety in our patient population than it would drive engagement. We did not add streaks. Our 90-day patient retention was 71%. The growth advisor&#8217;s other client, a general wellness app with streaks, had 23% 90-day retention. Clinical integrity is a retention strategy.&#8221;, Series A mental health founder, LA.<\/span><\/p>\n<h2><b>PSYPACT, Licensure, and Multi-State Mental Health Practice<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Mental health licensure for telehealth is more complex than general medical licensure because the mental health professional workforce has more provider types, more licensing frameworks, and more compact structures to navigate.<\/span><\/p>\n<h3><b>Provider type licensing framework:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Psychiatrists (MD\/DO):<\/b><span style=\"font-weight: 400;\"> Licensed under state medical boards. Interstate compact: Interstate Medical Licensure Compact (IMLC, 40+ states). Can prescribe, full prescribing authority including controlled substances (DEA registration required). Highest regulatory complexity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Psychologists (PhD\/PsyD):<\/b><span style=\"font-weight: 400;\"> Licensed under state psychology boards. Interstate compact: PSYPACT (Psychology Interjurisdictional Compact, 42 states as of 2026). Cannot prescribe in most states (exceptions: New Mexico, Louisiana, and Idaho have limited prescribing authority for psychologists). PSYPACT authorizes an Authority to Practice Interjurisdictional Telepsychology (APIT), a separate authorization from the state license that must be obtained and maintained.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Licensed Professional Counselors (LPCs) \/ Licensed Mental Health Counselors (LMHCs):<\/b><span style=\"font-weight: 400;\"> Title varies by state. Licensed under state counseling boards. Interstate compact: Counseling Compact (active in 30+ states as of 2026, expanding). Cannot prescribe. Most common provider type on general therapy platforms.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Licensed Clinical Social Workers (LCSWs):<\/b><span style=\"font-weight: 400;\"> Licensed under state social work boards. No active interstate compact as of 2026, the Social Work Licensure Compact has been adopted in several states but is still developing. Interstate practice requires individual state licenses. Cannot prescribe.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Marriage and Family Therapists (MFTs \/ LMFTs):<\/b><span style=\"font-weight: 400;\"> Licensed under state MFT or counseling boards. No active interstate compact as of 2026. Interstate practice requires individual state licenses. Cannot prescribe.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Certified Peer Support Specialists:<\/b><span style=\"font-weight: 400;\"> Not licensed healthcare providers. Not subject to medical practice licensure laws. Cannot provide clinical diagnosis or treatment. Valuable for peer support models, not a substitute for licensed clinical care.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>The licensure enforcement implication:<\/b><span style=\"font-weight: 400;\"> Your platform&#8217;s licensure enforcement logic must handle multiple provider types, each with different compact coverage and different multi-state practice rules. A platform that applies IMLC logic to LCSWs (who have no active compact) will incorrectly allow LCSW-patient matches in states where the LCSW is not licensed.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Build your licensure enforcement as a configurable rules engine: provider type \u2192 applicable compact \u2192 compact member states \u2192 active license verification. When a provider type has no compact (LCSW, MFT), the logic defaults to requiring an individual state license for every state where the provider sees patients.<\/span><\/p>\n<p><b>Compliance trap:<\/b><span style=\"font-weight: 400;\"> PSYPACT authorizes an Authority to Practice Interjurisdictional Telepsychology (APIT), which is separate from the psychologist&#8217;s home state license and separate from any individual state licenses they may hold. A psychologist practicing via PSYPACT must have an active APIT in addition to their home state license. Your credentialing system must track APIT status separately from state license status. An expired or lapsed APIT means the psychologist cannot see patients in PSYPACT member states, even if their home state license is current.<\/span><\/p>\n<h2><b>The Real Cost Stack for a Mental Health MVP in 2026<\/b><\/h2>\n<h3><b>Engineering (what you pay us):<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">HIPAA-ready Lean Mental Health MVP (therapy only, cash-pay, single-state, no AI): $95K\u2013$150K \/ 12\u201316 weeks<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Full Mental Health MVP (therapy + psychiatry, ePrescribe, multi-state, Part 2-compliant, crisis flow): $175K\u2013$265K \/ 18\u201324 weeks<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><a href=\"https:\/\/engineerbabu.com\/services\/ai-development\">AI-native development<\/a> mental health MVP (ambient documentation, risk detection, between-session AI check-ins, multi-state): $195K\u2013$300K \/ 20\u201326 weeks<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dedicated pod post-MVP: $25K\u2013$40K\/month<\/span><\/li>\n<\/ul>\n<h3><b>Compliance infrastructure:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">SOC 2 Type II audit: $45K\u2013$95K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">SOC 2 compliance tooling (Vanta, Drata): $12K\u2013$36K\/year<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Penetration testing: $8K\u2013$22K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">State mental health privacy law review (multi-state): $8K\u2013$20K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">42 CFR Part 2 applicability opinion and data model review: $4K\u2013$10K<\/span><\/li>\n<\/ul>\n<h3><b>Clinical infrastructure:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Clinical advisory board (2\u20133 licensed clinicians providing ongoing clinical oversight): $24K\u2013$60K\/year<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Medical director \/ Clinical director (fractional): $36K\u2013$84K\/year<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Crisis on-call coverage (after-hours clinical escalation for platform users): $24K\u2013$60K\/year depending on patient volume<\/span><\/li>\n<\/ul>\n<h3><b>Video infrastructure:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Same as telehealth guide, Daily.co on Scale plan, or Amazon Chime SDK for AWS-native builds<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">At 500 sessions\/month \u00d7 50 min avg: approximately $25\/month on Daily.co<\/span><\/li>\n<\/ul>\n<h3><b>ePrescribe (if psychiatry in scope):<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Same as telehealth guide, DrFirst ($25K\u2013$45K engineering, $12K\u2013$30K\/year licensing) or DoseSpot ($15K\u2013$28K engineering, $8K\u2013$20K\/year licensing)<\/span><\/li>\n<\/ul>\n<h3><b>Legal:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Healthcare attorney for mental health-specific consent documents: $6K\u2013$15K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Multi-state mandatory reporting law review: $5K\u2013$12K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PSYPACT and compact structure legal review: $3K\u2013$8K<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Malpractice and liability insurance guidance: $2K\u2013$6K<\/span><\/li>\n<\/ul>\n<h3><b>Credentialing:<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Primary source verification per provider: $30\u2013$100 per provider per state<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PSYPACT APIT monitoring: included in most credentialing service plans<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ongoing license monitoring: $50\u2013$150\/provider\/year<\/span><\/li>\n<\/ul>\n<p><b>EB Index 2026:<\/b><span style=\"font-weight: 400;\"> The median total first-year cost for a US mental health MVP, engineering, compliance, clinical infrastructure, legal, credentialing, and video, was $398,000. The single largest non-engineering cost was clinical infrastructure (clinical advisory board, medical director, crisis on-call coverage) at $72,000 for the first year. Founders who underbudget clinical infrastructure build technically compliant products that are not clinically sound.<\/span><\/p>\n<p><b>What we&#8217;d cut:<\/b><span style=\"font-weight: 400;\"> For a pre-seed mental health founder with under $3M raised: launch therapy-only (no psychiatry), cash-pay, single-state with a small credentialed therapist network, and a validated crisis flow. No ePrescribe, no multi-state, no AI features in v1. The clinical validation and the regulatory foundation take priority over feature breadth. Add psychiatry and prescribing at Series A when you have the funding for the full ePrescribe integration and the additional regulatory complexity it brings.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22992\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh5_cost_timeline-1.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>The 14-Week Mental Health MVP Sprint<\/b><\/h2>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 1: Discovery, Clinical Scoping, and Compliance Mapping<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Clinical scope defined (therapy only vs. therapy + psychiatry). Provider type inventory. 42 CFR Part 2 applicability determined. ePHI data classification map produced, with psychotherapy notes as a separate data category from Day 1. Licensure compact applicability mapped for each provider type. Crisis protocol designed (clinical stakeholders must be in this conversation, not just engineering). BAA vendor list completed.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 2: BAA Execution, Architecture Design, and Clinical Advisory<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">BAA signed. Psychotherapy notes data model designed, separate data store, separate access controls. Crisis flow architecture designed: risk language detection, automated crisis resources, therapist crisis tools, clinical escalation workflow, crisis documentation schema. HIPAA risk assessment v1 started. 42 CFR Part 2 consent framework designed (if applicable).<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 3: Infrastructure Provisioning<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">HIPAA-eligible cloud infrastructure provisioned. Separate encrypted data store for psychotherapy notes configured. Audit log service deployed with separate logging for psychotherapy note access. Crisis resource integration tested (988 API, Crisis Text Line integration if applicable). CI\/CD pipeline with SAST live.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 4: Provider Onboarding and Credentialing Workflow<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Provider onboarding flow built. Primary source license verification integration (by provider type, with compact verification for PSYPACT\/Counseling Compact). Psychotherapy notes data model implemented. HIPAA risk assessment v1 completed.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Weeks 5\u20136: Patient Intake, Matching, and Consent<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Patient registration with identity verification. Clinical intake (PHQ-9, GAD-7, C-SSRS safety screening). Mental health-specific informed consent collection and storage (attorney-drafted). Provider matching with licensure enforcement (by provider type, by patient state, by compact coverage). First session scheduling.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 7: Crisis Flow Build, Priority Sprint<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Week 7 is dedicated to the crisis flow. Risk language detection (keyword matching + AI flag if applicable). Automated crisis resource surfacing (within-app, within two taps). Embedded C-SSRS in session interface. Safety planning tool. Clinical escalation workflow (one-click supervisor alert). Crisis documentation schema. Welfare check workflow. This week does not move to the next sprint until the crisis flow is complete and clinically reviewed.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 8: Video Session and Therapist UX<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">HIPAA-compliant video session (Daily.co or Amazon Chime SDK). Therapist caseload dashboard. Session scheduling with therapist-controlled availability. Between-session messaging with risk language detection integrated.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 9: Clinical Documentation<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Progress note template (general progress notes). Psychotherapy notes interface (separate from general progress notes, separate access controls). AI-assisted SOAP note generation from session transcript (if in scope for v1). Post-session documentation workflow.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 10: Patient Engagement Features<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Mood check-in (PHQ-2 \/ GAD-2). Pre-session and post-session reflection prompts. Crisis resource persistent access (one persistent &#8220;Get Help Now&#8221; button accessible from every screen). Patient record access (right of access under HIPAA, excluding psychotherapy notes).<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 11: ePrescribe Integration (if psychiatry in scope)<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">DrFirst or DoseSpot integration. EPCS prescriber enrollment (should have started in Week 2, confirm status). Drug database and pharmacy directory. Prescription transmission and status tracking.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 12: Internal QA and Compliance Review<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Full crisis flow testing (all four crisis scenarios from Section 7). HIPAA-specific test suite (session timeout, access controls, psychotherapy notes separation, audit log, Part 2 consent if applicable). HIPAA risk assessment updated to as-built. Data flow diagrams produced.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 13: Penetration Testing and Clinical Review<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Third-party pen test. Clinical advisory board review of crisis flow, patient engagement features, and AI features (if in scope). Clinical team sign-off required before go-live. SOC 2 compliance platform connected.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Week 14: Handover and Launch<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Handover pack delivered including crisis protocol documentation, mandatory reporting workflow documentation, psychotherapy notes data model documentation, and Part 2 consent framework documentation (if applicable). Launch, but only after the clinical team has signed off on the crisis flow.<\/span><\/p>\n<h2><b>AI in Mental Health Products, The Highest-Stakes AI Build in Healthcare<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">AI in mental health products is the highest-stakes <a href=\"https:\/\/engineerbabu.com\/services\/ai-integration\">AI implementation<\/a> in healthcare. The clinical risks are real, the regulatory landscape is evolving rapidly, and the potential for harm, if an AI system performs incorrectly in a crisis moment or reinforces maladaptive patterns, is significant. Here is how we think about it.<\/span><\/p>\n<h3><b>AI use cases we build in mental health products:<\/b><\/h3>\n<ul>\n<li aria-level=\"1\"><b>Session documentation assistance:<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">AI-assisted progress note generation from session transcript. The lowest-risk AI use case in mental health, the AI is augmenting the therapist&#8217;s administrative workflow, not the clinical encounter. The therapist reviews and edits every AI-generated note before it becomes a clinical record. Build this. It recovers 10\u201314 minutes per session and is the single highest-ROI AI feature on a mental health platform.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">HIPAA requirements: session transcript is ePHI. Transcription service requires BAA (Amazon Transcribe Medical under the AWS BAA). AI processing of transcript requires BAA for the LLM provider (AWS Bedrock default). The generated note is ePHI. Explicit patient consent for ambient recording and AI-assisted documentation required in the informed consent framework.<\/span><\/p>\n<ul>\n<li aria-level=\"1\"><b>Between-session check-in analysis:<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">AI analysis of patient mood check-in data (PHQ-2 \/ GAD-2 scores over time, mood tracking trends, journal entry sentiment) to surface clinical insights to the therapist before the next session. &#8220;Patient&#8217;s PHQ-2 score has increased by 3 points over the last two weeks&#8221; is a useful clinical signal. The AI surfaces the signal. The therapist interprets it.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Risk: AI-generated clinical insights that are incorrect, misinterpreted, or over-weighted by a therapist who does not have time to review them carefully can contribute to missed deterioration or missed improvement. Every AI-generated clinical insight must be presented with appropriate uncertainty framing, as a signal to investigate, not as a clinical finding.<\/span><\/p>\n<ul>\n<li aria-level=\"1\"><b>Risk language detection:<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">AI NLP applied to patient-generated text (between-session messages, journal entries, mood check-in free text) to detect potential crisis language. This is a high-value safety feature with a significant false positive \/ false negative risk profile.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Implementation principle: AI flags, clinician assesses. An AI flag should trigger a therapist review, not an automated response that tells the patient they are in crisis when they are not, and not an automated non-response that fails to escalate genuine crisis signals. Every AI risk flag creates a clinical action item in the therapist&#8217;s queue. The therapist decides the clinical response.<\/span><\/p>\n<h3><b>What we do not build:<\/b><\/h3>\n<ul>\n<li aria-level=\"1\"><b>AI as the primary therapist:<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Products that position AI as the primary therapeutic relationship, chatbots that conduct therapy sessions, AI that provides clinical diagnoses, AI that makes treatment recommendations without licensed clinician oversight, are operating outside both the clinical and regulatory boundaries of mental health care. We do not build these. This is not a moral position, it is a clinical and regulatory one. The FDA has clear regulatory authority over software that is intended to diagnose or treat a mental health condition. A licensed clinician supervision layer is not optional for clinical AI in mental health.<\/span><\/p>\n<ul>\n<li aria-level=\"1\"><b>Sentiment analysis on session audio without patient consent:<\/b><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Any AI processing of session audio content for purposes beyond documentation (sentiment analysis, emotion detection, therapy quality scoring) requires explicit, specific patient consent beyond the documentation consent. The therapeutic relationship depends on the patient&#8217;s belief that what they say in session is confidential. AI analysis of the emotional content of their speech, beyond documentation, is a significant extension of the data use that must be disclosed and consented.<\/span><\/p>\n<p><b>Compliance trap:<\/b><span style=\"font-weight: 400;\"> The FDA&#8217;s 2023 digital health guidance and the evolving SaMD framework have specific implications for AI features in mental health products. An AI that is intended to detect depression, assess suicide risk, or recommend a specific treatment approach may meet the FDA&#8217;s definition of a Software as a Medical Device, triggering regulatory pathway requirements that go beyond HIPAA compliance. Before building any AI feature intended to diagnose or assess a mental health condition, get a regulatory attorney&#8217;s SaMD classification opinion. This is a $4K\u2013$8K investment that clarifies whether your AI feature is a product feature or a regulated medical device.<\/span><\/p>\n<h2><b>Post-Launch: Payer Contracting, Quality Metrics, and Network Expansion<\/b><\/h2>\n<p><b>Payer contracting for mental health:<\/b><span style=\"font-weight: 400;\"> Mental health parity laws (the Mental Health Parity and Addiction Equity Act, MHPAEA) require that commercial insurance plans cover mental health and substance use disorder treatment at parity with medical\/surgical benefits. In theory this means mental health telehealth should be reimbursable at the same rate as in-person care. In practice, payer contracting for mental health telehealth varies significantly by payer, by state, and by provider type.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The fastest paths to payer revenue for mental health platforms:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Employee Assistance Programs (EAPs):<\/b><span style=\"font-weight: 400;\"> Short-term therapy (typically 6\u201312 sessions) provided as an employer benefit. EAP contracting is faster than commercial insurance credentialing and provides a guaranteed volume of patients. The reimbursement rate is lower than commercial insurance, but the contracting process is shorter (weeks rather than months).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Medicaid:<\/b><span style=\"font-weight: 400;\"> State-by-state, but Medicaid expansion under the ACA has significantly broadened mental health coverage, and many states now cover telehealth mental health services at strong reimbursement rates. The credentialing process is state-administered and varies in complexity.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Direct-to-employer:<\/b><span style=\"font-weight: 400;\"> Contracting directly with self-insured employers to provide mental health benefits as a supplemental benefit. This requires a different sales process (HR benefits decision-makers rather than payer contracting departments) but can close faster and at higher per-session rates than traditional insurance.<\/span><\/li>\n<\/ul>\n<p><b>Quality metrics:<\/b><span style=\"font-weight: 400;\"> State mental health licensing boards, payers, and enterprise employer customers will increasingly ask for quality metrics. The metrics that matter for a mental health platform:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">PHQ-9 \/ GAD-7 score improvement over the course of treatment (clinical outcomes)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Session completion rate (attendance)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Therapist retention rate (clinical continuity)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Crisis event rate and response time (safety quality)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Patient-reported experience measures (PREMs)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Time to first appointment from patient registration (access quality)<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Build your outcomes measurement infrastructure from Day 1. Clinical outcomes data is your most powerful sales tool for enterprise and payer contracts, and it requires consistent data collection from the first patient session.<\/span><\/p>\n<p><b>Network expansion:<\/b><span style=\"font-weight: 400;\"> Each new provider type, each new state, and each new clinical specialty you add to the platform expands the licensure complexity. Build your provider onboarding, credentialing, and licensure enforcement systems as configurable infrastructure, not as hardcoded rules. A new compact joining PSYPACT (which happens regularly as states adopt the compact) should be a configuration update, not a codebase change.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-23000\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh6_outcomes_metrics-1.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>When an Indian Engineering Partner Is Wrong for Your Mental Health Build<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">An Indian engineering partner is the wrong call for your mental health product if: your product requires daily, in-depth clinical domain expertise embedded in engineering decisions, where the product and clinical teams need to be in the same room (or the same Zoom call) multiple times per day and the 10.5-hour time zone gap creates a clinical design bottleneck that the async-first model cannot resolve.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If your clinical advisory board or clinical director is not available during the US-India overlap window and requires spontaneous, synchronous clinical review of engineering decisions as they arise.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If your regulatory posture requires US-person handling of clinical records, certain federal mental health programs and certain state mental health programs with heightened data sovereignty requirements may create this constraint.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you are building a crisis response platform where product decisions have immediate patient safety implications and the latency of an async communication model is clinically unacceptable.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These are real constraints for a subset of mental health products. For most mental health platforms, therapy, psychiatry, peer support, the structured collaboration model with a defined US-overlap window, a US-based client lead, and a strong clinical advisory board embedded in the product process works well. I will tell you on the first call if your specific situation is one of the exceptions.<\/span><\/p>\n<h2><b>The Mental Health Product Scorecard\u2122<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Score each row 0 (absent), 1 (partial), or 2 (fully present). Maximum score: 70.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>#<\/b><\/td>\n<td><b>Criterion<\/b><\/td>\n<td><b>Weight<\/b><\/td>\n<td><b>Your Score<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Crisis flow designed and built before first patient session<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">2<\/span><\/td>\n<td><span style=\"font-weight: 400;\">C-SSRS embedded in session interface<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">3<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Safety planning tool in session interface<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">4<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Clinical escalation workflow (one-click supervisor alert)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">5<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Risk language detection in patient-generated text<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">6<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Psychotherapy notes stored separately from general clinical record<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">42 CFR Part 2 applicability determined and data model designed accordingly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">8<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Mental health-specific informed consent (attorney-drafted)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">9<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Mandatory reporting workflow documented and supported in product<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">10<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Licensure enforcement by provider type (PSYPACT, Counseling Compact, IMLC)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">11<\/span><\/td>\n<td><span style=\"font-weight: 400;\">HIPAA risk assessment completed before go-live<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">12<\/span><\/td>\n<td><span style=\"font-weight: 400;\">BAA coverage confirmed for every sub-processor touching ePHI<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">13<\/span><\/td>\n<td><span style=\"font-weight: 400;\">AI-assisted documentation with therapist review before clinical record<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">14<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Clinical advisory board review of AI features before deployment<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">15<\/span><\/td>\n<td><span style=\"font-weight: 400;\">SaMD classification opinion obtained for any diagnostic AI feature<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">16<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Between-session messaging with risk language detection<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">17<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No clinically harmful engagement features (streaks, urgency language)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/4<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">18<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Third-party penetration test completed before go-live<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">19<\/span><\/td>\n<td><span style=\"font-weight: 400;\">SOC 2 readiness built into architecture from Day 1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">20<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Patient outcomes measurement (PHQ-9 \/ GAD-7) built in from Day 1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">21<\/span><\/td>\n<td><span style=\"font-weight: 400;\">PSYPACT APIT tracking separate from home state license<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">22<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Crisis documentation with timestamp and structured fields<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">23<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Post-crisis follow-up workflow supported in platform<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">24<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Therapist schedule control (not auto-booked to capacity)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">25<\/span><\/td>\n<td><span style=\"font-weight: 400;\">MSA governed by US law with IP assignment on creation<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1\u00d7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\/2<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><b>Score interpretation:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">55\u201370: Strong clinical and compliance posture, ready for enterprise payer and EAP conversations<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">40\u201354: Proceed with identified gaps remediated, 2\u00d7 items are patient safety critical<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Under 40: Significant clinical and regulatory exposure, do not go live with real patients until gaps closed<\/span><\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-22990\" src=\"https:\/\/engineerbabu.com\/blog\/wp-content\/uploads\/2026\/05\/mh7_scorecard_mistakes.png\" alt=\"\" width=\"1500\" height=\"900\" title=\"\"><\/p>\n<h2><b>Conclusion<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Mental health products carry a level of clinical responsibility that most other digital health products do not. When a patient opens your app, they are trusting it with some of the most vulnerable moments of their life. The crisis flow that works correctly when a patient types &#8220;I don&#8217;t want to be here anymore.&#8221;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The psychotherapy notes stored separately, with the access controls that protect what a patient shared in confidence. The therapist UX that gives clinicians the tools to do their job without burning them out.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These are not regulatory checkboxes. They are the product. They are what it means to build a mental health platform that earns the trust patients are placing in it from the first session.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The founders who build this right are the ones who treat clinical integrity as the product constraint, the thing that shapes every architecture decision, every UX choice, every AI feature. Not as a compliance layer added at the end. As the foundation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you want to talk through your mental health product, what your clinical scope is, what your regulatory exposure looks like, what the right architecture is for where you are, book 30 minutes with me or Aditi. No slides. No pitch. Just the product conversation.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><i><span style=\"font-weight: 400;\">Mayank Pratap Singh is the co-founder and CEO of <a href=\"http:\/\/engineerbabu.com\">EngineerBabu<\/a>, a CMMI Level 5, Google AI Accelerator 2024 alumni product engineering studio based in Indore, India. EngineerBabu has shipped 1,200+ products since 2014, including 18+ mental health products for US healthcare founders. Book a product audit at engineerbabu.com\/discovery.<\/span><\/i><\/p>\n<h2><b>FAQ<\/b><\/h2>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Does HIPAA cover everything I need for a mental health product?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">HIPAA is the baseline. 42 CFR Part 2 adds stricter requirements for substance use disorder records. State mental health privacy laws, California CMIA, New York Mental Hygiene Law, Illinois MHDDCA, Texas HSC Chapter 611, and others, impose additional requirements that vary by state. Psychotherapy notes have special protected status under HIPAA (45 CFR \u00a7164.501) that requires separate data storage and more restrictive access controls than general clinical records.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is 42 CFR Part 2 and when does it apply?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">42 CFR Part 2 is a federal regulation that protects records related to substance use disorder treatment with stricter confidentiality requirements than HIPAA. It applies to any program that provides SUD diagnosis, treatment, or referral, and to any record that identifies a patient as having received SUD treatment from such a program. It requires specific, named consent for most disclosures, a general HIPAA authorization is not sufficient. Most broad mental health platforms eventually encounter Part 2 applicability as their patient population includes patients with co-occurring SUD.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is a psychotherapy note under HIPAA and why does it matter?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Under 45 CFR \u00a7164.501, a psychotherapy note is defined as notes recorded by a mental health professional in the process of counseling that are kept separate from the rest of the medical record. Psychotherapy notes have special protection, they cannot be included in a general medical record disclosure, they require a separate specific authorization for release, and the patient&#8217;s right of access does not automatically extend to them. Your data model must store psychotherapy notes separately from general progress notes with separate, more restrictive access controls.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>Can AI conduct therapy sessions?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">AI can support therapy, session documentation, between-session check-ins, psychoeducation, mood tracking analysis. AI cannot replace a licensed therapist for the treatment of clinical mental health conditions. Products that position AI as the primary therapeutic relationship without licensed clinician oversight are operating outside both clinical best practices and evolving FDA regulatory guidance on SaMD. Build AI as a support layer, not as the clinician.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>How does PSYPACT work for a multi-state psychology practice?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">PSYPACT allows licensed psychologists to practice across 42 member states under an Authority to Practice Interjurisdictional Telepsychology (APIT), a separate authorization from their home state license. The psychologist applies for an APIT through the PSYPACT Commission, maintaining their home state license as the foundation. The APIT must be renewed and monitored separately. Your credentialing system must track APIT status separately from state license status.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What engagement features are inappropriate for mental health products?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Streak mechanics (can cause anxiety in anxiety-disorder populations), urgency language in notifications, gamification of clinical assessments, auto-renewal of therapy subscriptions without explicit patient confirmation, comparison features benchmarking patient progress against other patients, and any feature designed to maximize app-open frequency rather than clinical outcomes. Every engagement design decision in a mental health product should be reviewed by a licensed clinician before implementation.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>What is the 988 Suicide and Crisis Lifeline and do I need to integrate it?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">988 is the three-digit dialing code for the National Suicide Prevention Lifeline, active since July 2022. It provides call, text, and chat access to crisis support. Your mental health product must surface 988 as a crisis resource, at minimum, a persistent, accessible link to the 988 resource from any screen in the application. More robust integration: embedding the 988 chat API within your product so patients can initiate a crisis chat without leaving the app. The Vibrant Emotional Health organization, which operates the 988 network, provides API documentation for integration.<\/span><\/p>\n<ul>\n<li aria-level=\"1\">\n<h3><b>How long must mental health records be retained?<\/b><\/h3>\n<\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">HIPAA minimum: 6 years from the date of creation or the date last in effect, whichever is later. State requirements vary and are often longer, California requires 10 years from the date of service for adult patients. Minnesota requires records to be retained for a minimum of 7 years. Build your retention policy around the most restrictive requirement that applies to your patient population. Build the automated deletion workflow before you have records that need to be deleted, manual deletion at scale is operationally unsustainable and creates compliance risk.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In January 2023, a mental health founder in New York, Seed stage, $3.8M raised, building a platform connecting patients with licensed therapists for weekly video sessions, got a call from a therapist on her network. A patient had typed &#8220;I don&#8217;t want to be here anymore&#8221; into the in-platform chat during a session. The therapist [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":22987,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1246],"tags":[],"class_list":["post-22966","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthtech"],"_links":{"self":[{"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/posts\/22966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/comments?post=22966"}],"version-history":[{"count":4,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/posts\/22966\/revisions"}],"predecessor-version":[{"id":23002,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/posts\/22966\/revisions\/23002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/media\/22987"}],"wp:attachment":[{"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/media?parent=22966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/categories?post=22966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/engineerbabu.com\/blog\/wp-json\/wp\/v2\/tags?post=22966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}